<?xml version="1.0" encoding="UTF-8"?>
<p>The current preclinical and clinical data regarding the use of CQ and HCQ in SARS-CoV-2 infection are not considered robust [
 <xref rid="B102-jcm-09-02084" ref-type="bibr">102</xref>], and EMA did not approve chloroquine for standard use in COVID-19 pathology and restricted its use exclusively in clinical trials or through national emergency use programs [
 <xref rid="B101-jcm-09-02084" ref-type="bibr">101</xref>,
 <xref rid="B106-jcm-09-02084" ref-type="bibr">106</xref>].
</p>
